Nationwide survey of patients with primary immunodeficiency diseases in Japan

J Clin Immunol. 2011 Dec;31(6):968-76. doi: 10.1007/s10875-011-9594-7. Epub 2011 Sep 29.

Abstract

To determine the prevalence and clinical characteristics of patients with in Japan, we conducted a nationwide survey of primary immunodeficiency disease (PID) patients for the first time in 30 years. Questionnaires were sent to 1,224 pediatric departments and 1,670 internal medicine departments of Japanese hospitals. A total of 1,240 patients were registered. The estimated number of patients with PID was 2,900 with a prevalence of 2.3 per 100,000 people and homogenous regional distribution in Japan. The male-to-female ratio was 2.3:1 with a median age of 12.8 years. Adolescents or adults constituted 42.8% of the patients. A number of 25 (2.7%) and 78 (8.5%) patients developed malignant disorders and immune-related diseases, respectively, as complications of primary immunodeficiency disease. Close monitoring and appropriate management for these complications in addition to prevention of infectious diseases is important for improving the quality of life of PID patients.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Agammaglobulinaemia Tyrosine Kinase
  • Antibodies / genetics
  • Antibodies / immunology
  • Antibodies / metabolism*
  • Autoimmunity / genetics
  • Child
  • Female
  • Health Surveys
  • Humans
  • Immunoglobulin A / genetics
  • Immunologic Deficiency Syndromes / epidemiology*
  • Immunologic Deficiency Syndromes / genetics
  • Immunologic Deficiency Syndromes / immunology
  • Immunologic Deficiency Syndromes / physiopathology*
  • Japan / epidemiology
  • Male
  • Phagocytes / immunology
  • Phagocytes / metabolism*
  • Phagocytes / pathology
  • Prevalence
  • Protein-Tyrosine Kinases / genetics
  • Surveys and Questionnaires

Substances

  • Antibodies
  • Immunoglobulin A
  • Protein-Tyrosine Kinases
  • Agammaglobulinaemia Tyrosine Kinase